Market Tracker

02/22 2:39pm ET
0.4862
BATS BZX Real-Time Price
As of 2:39pm ET
 -0.0235 / -4.61%
Today’s Change
0.41
Today|||52-Week Range
2.24
-23.64%
Year-to-Date
No recent news for MannKind Corp.

Today’s Trading

Previous close0.51
Today’s open0.51
Day’s range0.48 - 0.51
Volume70,606
Average volume (3 months)4,899,128
Market cap$244.0M
Dividend yield--
Data as of 2:39pm ET, 02/22/2017

Growth & Valuation

Earnings growth (last year)-78.43%
Earnings growth (this year)+112.64%
Earnings growth (next 5 years)+26.80%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
IDRAIdera Pharmaceutical...+0.03+1.81%
PETXAratana Therapeutics...-0.01-0.15%
TTPHTetraphase Pharmaceu...+0.08+1.54%
TGTXTG Therapeutics Inc+0.42+9.04%
Data as of 2:38pm ET, 02/22/2017

Financials

Next reporting dateMarch 20, 2017
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$0.00
Annual profit (last year)-$368.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
CEO, CFO, Director, VP &
Head-Investor Relations
Matthew J. Pfeffer
Chief Medical Officer &
Vice President
Raymond W. Urbanski
Corporate headquarters
Valencia, California

Forecasts